Page last updated: 2024-09-05

ergolide and Leukemia

ergolide has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Darbandi, A; Gharehbaghian, A; Hamzeloo-Moghadam, M; Karami, A; Mashati, P; Takhviji, V; Yami, A	1

Other Studies

1 other study(ies) available for ergolide and Leukemia

Article	Year
Ergolide, a potent sesquiterpene lactone induces cell cycle arrest along with ROS-dependent apoptosis and potentiates vincristine cytotoxicity in ALL cell lines. Journal of ethnopharmacology, 2020, May-10, Volume: 253 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Inhibitory Concentration 50; Inula; Lactones; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Sesquiterpenes; Vincristine	2020

Article

Year

Ergolide, a potent sesquiterpene lactone induces cell cycle arrest along with ROS-dependent apoptosis and potentiates vincristine cytotoxicity in ALL cell lines.

Journal of ethnopharmacology, 2020, May-10, Volume: 253

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Inhibitory Concentration 50; Inula; Lactones; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Sesquiterpenes; Vincristine

2020